On May 16, the Centers for Medicare & Medicaid Services(CMS) released their final rule titled “Modernizing Part D and MedicareAdvantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” Highlightsfrom this final rule include:
The ACCC policy team will continue to analyze this rule andprovide a more detailed analysis at a later date.
Readthe CMS final rule here.
Posted 5/17/2019
Decentralized clinical trial approaches, including remote consent, telehealth, local laboratory and imaging services, and more, can help reduce some of the many barriers that prevent eligible patients from participating in trials. But as the participants in ACCC’s Advancing Decentralized Clinical Trials in the Community Setting Roundtable Series emphasized, implementing DCT elements is not simply a matter of adopting new technology. Doing so successfully requires thoughtful workflows and oversight structures that consider equity, scalability, and sustainability.
